A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study

Hideki Mizunuma(Hirosaki University), Yoshihito Yokoyama(Hirosaki University), Akira Sato(Unknown), Tadao Takano(Tohoku University), Hirokazu Sato(Shanghai Institute for Science of Science), Hidekazu Yamada(Fukushima Medical University), Tadahiro Shoji(Iwate Medical University), Toru Sugiyama(St Mary's Hospital), Toshinobu Tanaka(University of Occupational and Environmental Health Japan), Hirohisa Kurachi(Osaka Women's and Children's Hospital), Kunihiro Okamura(Tohoku University), Nobuo Yaegashi(Tohoku University), Toru Tase(Miyagi Prefectural Hospital Organization), Kenji Nakahara(Yamagata University)
Oncology Reports
June 1, 2008
10.3892/or.19.6.1551
Cited by 27

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
The Tohoku Medical Megabank Project: Design and Mission
|Journal of Epidemiology|2016|386
Wnt5a regulates distinct signalling pathways by binding to Frizzled2
|The EMBO Journal|2009|319
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
|Molecular Cancer Research|2016|232